XClose

Towers Lab

Menu

. . . . . . .

Towers Lab

In the Towers Lab we aim to understand the molecular details of host virus interactions particularly with respect to innate immunity. We consider novel therapeutic approaches for viral infection and inflammation and to use viruses to help us understand mammalian cell biology and evolution. We also want to know what is special about pandemic viruses HIV-1(M) and SARS-CoV-2 and how have they adapted to replicate in humans and cause disease.

NEWS
Lucy, Matt, Lorena and AK, June 2021

 

"How the 'Aplha' Coronavirus Variant Became So Powerful". The Towers and collaborators including Jolly and Krogen lab's work is featured in The New York Times. Carl Zimmer interviewed Prof Greg Towers and Prof Nevan Krogan to discuss how the Alpha Variant evades immune responses.

 

 

 

False coloured SEM image of 283T cells in culture. Image is copyrighted. It was taken on SEM by Steve Gschmeissner. To see more of his work, visit http://theworldcloseup.com/
Virtual Virology

The Towers laboratory we share with the Gupta and Rowe labs. Image courtsey of the Wellcome Trust
The Lab

nd-10cm-dish_pqr2293-800x480
Work with Us

False coloured SEM image of a platelet found as a contaminant in a primary monocyte culture. Image is copyrighted. It was taken on SEM by Steve Gschmeissner. To see more of his work, visit http://theworldcloseup.com/
Contact Us

 

We are funded by a Senior Biomedical Research Fellowship No 108183 from Wellcome to Professor Greg Towers and a Wellcome collaborative award as well as grants from the Medical Research Council and the National Institute for Health Research.

Wellcome Turst logo

UCL COVID-19 Rapid Response Fund

NIHR logo

MRC logo